Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells
- PMID: 18376405
- DOI: 10.1038/nm1745
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells
Abstract
Cell-free human T-lymphotropic virus type 1 (HTLV-1) virions are poorly infectious in vitro for their primary target cells, CD4(+) T cells. Here, we show that HTLV-1 can efficiently infect myeloid and plasmacytoid dendritic cells (DCs). Moreover, DCs exposed to HTLV-1, both before and after being productively infected, can rapidly, efficiently and reproducibly transfer virus to autologous primary CD4(+) T cells. This DC-mediated transfer of HTLV-1 involves heparan sulfate proteoglycans and neuropilin-1 and results in long-term productive infection and interleukin-2-independent transformation of the CD4(+) T cells. These studies, along with observations of HTLV-1-infected DCs in the peripheral blood of infected individuals, indicate that DCs have a central role in HTLV-1 transmission, dissemination and persistence in vivo. In addition to altering the current paradigm concerning how HTLV-1 transmission occurs, these studies suggest that impairment of DC function after HTLV-1 infection plays a part in pathogenesis.
Similar articles
-
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.PLoS Pathog. 2017 Apr 20;13(4):e1006353. doi: 10.1371/journal.ppat.1006353. eCollection 2017 Apr. PLoS Pathog. 2017. PMID: 28426803 Free PMC article.
-
Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.J Virol. 2015 Oct;89(20):10580-90. doi: 10.1128/JVI.01799-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269171 Free PMC article.
-
DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.J Virol. 2009 Nov;83(21):10908-21. doi: 10.1128/JVI.01054-09. Epub 2009 Aug 19. J Virol. 2009. PMID: 19692463 Free PMC article.
-
Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.Rev Med Virol. 2013 Sep;23(5):269-80. doi: 10.1002/rmv.1745. Epub 2013 Apr 22. Rev Med Virol. 2013. PMID: 23606621 Review.
-
Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.J Virol. 2016 Aug 12;90(17):7607-17. doi: 10.1128/JVI.00407-16. Print 2016 Sep 1. J Virol. 2016. PMID: 27334587 Free PMC article. Review.
Cited by
-
Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.J Virol. 2024 Feb 20;98(2):e0186223. doi: 10.1128/jvi.01862-23. Epub 2024 Jan 31. J Virol. 2024. PMID: 38294250 Free PMC article.
-
Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion.Int J Mol Sci. 2023 Nov 20;24(22):16520. doi: 10.3390/ijms242216520. Int J Mol Sci. 2023. PMID: 38003710 Free PMC article.
-
Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.Med Oncol. 2023 Sep 9;40(10):295. doi: 10.1007/s12032-023-02166-8. Med Oncol. 2023. PMID: 37689806 Review.
-
Milk Transmission of Mammalian Retroviruses.Microorganisms. 2023 Jul 8;11(7):1777. doi: 10.3390/microorganisms11071777. Microorganisms. 2023. PMID: 37512949 Free PMC article. Review.
-
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.Mol Pharm. 2023 Aug 7;20(8):3698-3740. doi: 10.1021/acs.molpharmaceut.2c01080. Epub 2023 Jul 24. Mol Pharm. 2023. PMID: 37486263 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
